KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Equity Average (2016 - 2026)

Evolent Health has reported Equity Average over the past 11 years, most recently at $628.7 million for Q4 2025.

  • For Q4 2025, Equity Average fell 38.36% year-over-year to $628.7 million; the TTM value through Dec 2025 reached $628.7 million, down 38.36%, while the annual FY2025 figure was $708.2 million, 31.54% down from the prior year.
  • Equity Average for Q4 2025 was $628.7 million at Evolent Health, down from $869.1 million in the prior quarter.
  • Over five years, Equity Average peaked at $1.1 billion in Q2 2023 and troughed at $610.8 million in Q3 2021.
  • A 5-year average of $874.4 million and a median of $919.5 million in 2021 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: surged 80.92% in 2023 and later crashed 38.36% in 2025.
  • Year by year, Equity Average stood at $650.6 million in 2021, then surged by 31.85% to $857.8 million in 2022, then grew by 26.13% to $1.1 billion in 2023, then dropped by 5.72% to $1.0 billion in 2024, then crashed by 38.36% to $628.7 million in 2025.
  • Business Quant data shows Equity Average for EVH at $628.7 million in Q4 2025, $869.1 million in Q3 2025, and $915.8 million in Q2 2025.